Literature DB >> 17557070

Decline in breast cancer incidence--United States, 1999-2003.

.   

Abstract

Breast cancer is the most commonly diagnosed cancer among females in the United States. The 2006 Annual Report to the Nation on the Status of Cancer described a stabilization in female breast cancer incidence rates during 2001-2003, ending increases that began in the 1980s, and a decline in the number of breast cancer cases diagnosed in 2003. In addition, researchers who used 1990-2003 data from the National Cancer Institute's (NCI's) Surveillance, Epidemiology, and End Results (SEER) program, representing approximately 14% of the U.S. population, reported a 7% decrease in invasive breast cancer rates from 2002 to 2003. To further assess breast cancer annual incidence rates during 1999-2003, CDC analyzed data collected by CDC's National Program of Cancer Registries (NPCR) and the NCI SEER program. These combined data account for approximately 86% of the U.S. population. The results of this analysis indicated that age-adjusted incidence rates for invasive breast cancer decreased each year during 1999-2003, with the greatest decrease (6.1%) occurring from 2002 to 2003; women aged > or = 50 years experienced a significant decrease during this period. Rates of in situ (i.e., noninvasive) breast cancer increased each year during 1999-2002 and then decreased from 2002 to 2003; women aged 50-79 years experienced a significant decrease during this period. Future studies should focus on determining potential causes for these decreases.

Entities:  

Mesh:

Year:  2007        PMID: 17557070

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

Review 2.  Current approaches to the treatment of metastatic brain tumours.

Authors:  Taofeek K Owonikoko; Jack Arbiser; Amelia Zelnak; Hui-Kuo G Shu; Hyunsuk Shim; Adam M Robin; Steven N Kalkanis; Timothy G Whitsett; Bodour Salhia; Nhan L Tran; Timothy Ryken; Michael K Moore; Kathleen M Egan; Jeffrey J Olson
Journal:  Nat Rev Clin Oncol       Date:  2014-02-25       Impact factor: 66.675

3.  Decline in US breast cancer rates after the Women's Health Initiative: socioeconomic and racial/ethnic differentials.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.

Authors:  Theresa H M Keegan; Ellen T Chang; Esther M John; Pamela L Horn-Ross; Margaret R Wrensch; Sally L Glaser; Christina A Clarke
Journal:  Breast Cancer Res       Date:  2007-09-25       Impact factor: 6.466

5.  Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse.

Authors:  Andreas Stang
Journal:  Dtsch Arztebl Int       Date:  2008-04-18       Impact factor: 5.594

6.  The decline in breast cancer incidence: real or imaginary?

Authors:  Allison W Kurian; Christina A Clarke; Robert W Carlson
Journal:  Curr Oncol Rep       Date:  2009-01       Impact factor: 5.075

7.  Invasive breast cancer incidence trends by detailed race/ethnicity and age.

Authors:  Lihua Liu; Juanjuan Zhang; Anna H Wu; Malcolm C Pike; Dennis Deapen
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.316

8.  Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer.

Authors:  Belinda Seto
Journal:  Clin Transl Med       Date:  2012-11-15

9.  Trends in breast cancer incidence among women under the age of forty.

Authors:  F Levi; V-C Te; M Maspoli; L Randimbison; J-L Bulliard; C La Vecchia
Journal:  Br J Cancer       Date:  2007-08-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.